Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01202045

Stress Echocardiography in the Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis Patients

Stress Echocardiography in the Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis Patients With Indirect Signs of Pulmonary Arterial Hypertension

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Paul Farand · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the value in terms of sensitivity, specificity and likelihood ratio of the stress echocardiography in the screening of pulmonary arterial hypertension in patients with systemic sclerosis and indirect signs of pulmonary arterial hypertension.

Detailed description

Pulmonary artery catheterization (rest and exertion) and treadmill stress echocardiography will be done to all patients of the study.

Conditions

Timeline

Start date
2010-09-01
Primary completion
2011-10-01
Completion
2011-10-01
First posted
2010-09-15
Last updated
2013-07-08

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01202045. Inclusion in this directory is not an endorsement.

Stress Echocardiography in the Detection of Pulmonary Arterial Hypertension in Systemic Sclerosis Patients (NCT01202045) · Clinical Trials Directory